Global Pasireotide Market Growth 2022-2028
- LP 4871613
- 75 Pages
- February 2022
- Pharmaceuticals
The United States Pasireotide market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pasireotide market, reaching US$ million by the year 2028. As for the Europe Pasireotide landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pasireotide players cover Novartis, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pasireotide market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
0.3mg/ml
0.6mg/ml
0.9mg/ml
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Pharmacy
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Pasireotide Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Pasireotide by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Pasireotide by Country/Region, 2017, 2022 & 2028
2.2 Pasireotide Segment by Type
2.2.1 0.3mg/ml
2.2.2 0.6mg/ml
2.2.3 0.9mg/ml
2.3 Pasireotide Sales by Type
2.3.1 Global Pasireotide Sales Market Share by Type (2017-2022)
2.3.2 Global Pasireotide Revenue and Market Share by Type (2017-2022)
2.3.3 Global Pasireotide Sale Price by Type (2017-2022)
2.4 Pasireotide Segment by Application
2.4.1 Hospital
2.4.2 Pharmacy
2.5 Pasireotide Sales by Application
2.5.1 Global Pasireotide Sale Market Share by Application (2017-2022)
2.5.2 Global Pasireotide Revenue and Market Share by Application (2017-2022)
2.5.3 Global Pasireotide Sale Price by Application (2017-2022)
3 Global Pasireotide by Company
3.1 Global Pasireotide Breakdown Data by Company
3.1.1 Global Pasireotide Annual Sales by Company (2020-2022)
3.1.2 Global Pasireotide Sales Market Share by Company (2020-2022)
3.2 Global Pasireotide Annual Revenue by Company (2020-2022)
3.2.1 Global Pasireotide Revenue by Company (2020-2022)
3.2.2 Global Pasireotide Revenue Market Share by Company (2020-2022)
3.3 Global Pasireotide Sale Price by Company
3.4 Key Manufacturers Pasireotide Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pasireotide Product Location Distribution
3.4.2 Players Pasireotide Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Pasireotide by Geographic Region
4.1 World Historic Pasireotide Market Size by Geographic Region (2017-2022)
4.1.1 Global Pasireotide Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Pasireotide Annual Revenue by Geographic Region
4.2 World Historic Pasireotide Market Size by Country/Region (2017-2022)
4.2.1 Global Pasireotide Annual Sales by Country/Region (2017-2022)
4.2.2 Global Pasireotide Annual Revenue by Country/Region
4.3 Americas Pasireotide Sales Growth
4.4 APAC Pasireotide Sales Growth
4.5 Europe Pasireotide Sales Growth
4.6 Middle East & Africa Pasireotide Sales Growth
5 Americas
5.1 Americas Pasireotide Sales by Country
5.1.1 Americas Pasireotide Sales by Country (2017-2022)
5.1.2 Americas Pasireotide Revenue by Country (2017-2022)
5.2 Americas Pasireotide Sales by Type
5.3 Americas Pasireotide Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pasireotide Sales by Region
6.1.1 APAC Pasireotide Sales by Region (2017-2022)
6.1.2 APAC Pasireotide Revenue by Region (2017-2022)
6.2 APAC Pasireotide Sales by Type
6.3 APAC Pasireotide Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Pasireotide by Country
7.1.1 Europe Pasireotide Sales by Country (2017-2022)
7.1.2 Europe Pasireotide Revenue by Country (2017-2022)
7.2 Europe Pasireotide Sales by Type
7.3 Europe Pasireotide Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Pasireotide by Country
8.1.1 Middle East & Africa Pasireotide Sales by Country (2017-2022)
8.1.2 Middle East & Africa Pasireotide Revenue by Country (2017-2022)
8.2 Middle East & Africa Pasireotide Sales by Type
8.3 Middle East & Africa Pasireotide Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pasireotide
10.3 Manufacturing Process Analysis of Pasireotide
10.4 Industry Chain Structure of Pasireotide
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pasireotide Distributors
11.3 Pasireotide Customer
12 World Forecast Review for Pasireotide by Geographic Region
12.1 Global Pasireotide Market Size Forecast by Region
12.1.1 Global Pasireotide Forecast by Region (2023-2028)
12.1.2 Global Pasireotide Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pasireotide Forecast by Type
12.7 Global Pasireotide Forecast by Application
13 Key Players Analysis
13.1 Novartis
13.1.1 Novartis Company Information
13.1.2 Novartis Pasireotide Product Offered
13.1.3 Novartis Pasireotide Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Novartis Main Business Overview
13.1.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Pasireotide Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Pasireotide Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of 0.3mg/ml
Table 4. Major Players of 0.6mg/ml
Table 5. Major Players of 0.9mg/ml
Table 6. Global Pasireotide Sales by Type (2017-2022) & (K Units)
Table 7. Global Pasireotide Sales Market Share by Type (2017-2022)
Table 8. Global Pasireotide Revenue by Type (2017-2022) & ($ million)
Table 9. Global Pasireotide Revenue Market Share by Type (2017-2022)
Table 10. Global Pasireotide Sale Price by Type (2017-2022) & (USD/Unit)
Table 11. Global Pasireotide Sales by Application (2017-2022) & (K Units)
Table 12. Global Pasireotide Sales Market Share by Application (2017-2022)
Table 13. Global Pasireotide Revenue by Application (2017-2022)
Table 14. Global Pasireotide Revenue Market Share by Application (2017-2022)
Table 15. Global Pasireotide Sale Price by Application (2017-2022) & (USD/Unit)
Table 16. Global Pasireotide Sales by Company (2020-2022) & (K Units)
Table 17. Global Pasireotide Sales Market Share by Company (2020-2022)
Table 18. Global Pasireotide Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Pasireotide Revenue Market Share by Company (2020-2022)
Table 20. Global Pasireotide Sale Price by Company (2020-2022) & (USD/Unit)
Table 21. Key Manufacturers Pasireotide Producing Area Distribution and Sales Area
Table 22. Players Pasireotide Products Offered
Table 23. Pasireotide Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pasireotide Sales by Geographic Region (2017-2022) & (K Units)
Table 27. Global Pasireotide Sales Market Share Geographic Region (2017-2022)
Table 28. Global Pasireotide Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Pasireotide Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Pasireotide Sales by Country/Region (2017-2022) & (K Units)
Table 31. Global Pasireotide Sales Market Share by Country/Region (2017-2022)
Table 32. Global Pasireotide Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Pasireotide Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Pasireotide Sales by Country (2017-2022) & (K Units)
Table 35. Americas Pasireotide Sales Market Share by Country (2017-2022)
Table 36. Americas Pasireotide Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Pasireotide Revenue Market Share by Country (2017-2022)
Table 38. Americas Pasireotide Sales by Type (2017-2022) & (K Units)
Table 39. Americas Pasireotide Sales Market Share by Type (2017-2022)
Table 40. Americas Pasireotide Sales by Application (2017-2022) & (K Units)
Table 41. Americas Pasireotide Sales Market Share by Application (2017-2022)
Table 42. APAC Pasireotide Sales by Region (2017-2022) & (K Units)
Table 43. APAC Pasireotide Sales Market Share by Region (2017-2022)
Table 44. APAC Pasireotide Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Pasireotide Revenue Market Share by Region (2017-2022)
Table 46. APAC Pasireotide Sales by Type (2017-2022) & (K Units)
Table 47. APAC Pasireotide Sales Market Share by Type (2017-2022)
Table 48. APAC Pasireotide Sales by Application (2017-2022) & (K Units)
Table 49. APAC Pasireotide Sales Market Share by Application (2017-2022)
Table 50. Europe Pasireotide Sales by Country (2017-2022) & (K Units)
Table 51. Europe Pasireotide Sales Market Share by Country (2017-2022)
Table 52. Europe Pasireotide Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Pasireotide Revenue Market Share by Country (2017-2022)
Table 54. Europe Pasireotide Sales by Type (2017-2022) & (K Units)
Table 55. Europe Pasireotide Sales Market Share by Type (2017-2022)
Table 56. Europe Pasireotide Sales by Application (2017-2022) & (K Units)
Table 57. Europe Pasireotide Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Pasireotide Sales by Country (2017-2022) & (K Units)
Table 59. Middle East & Africa Pasireotide Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Pasireotide Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Pasireotide Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Pasireotide Sales by Type (2017-2022) & (K Units)
Table 63. Middle East & Africa Pasireotide Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Pasireotide Sales by Application (2017-2022) & (K Units)
Table 65. Middle East & Africa Pasireotide Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Pasireotide
Table 67. Key Market Challenges & Risks of Pasireotide
Table 68. Key Industry Trends of Pasireotide
Table 69. Pasireotide Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Pasireotide Distributors List
Table 72. Pasireotide Customer List
Table 73. Global Pasireotide Sales Forecast by Region (2023-2028) & (K Units)
Table 74. Global Pasireotide Sales Market Forecast by Region
Table 75. Global Pasireotide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Pasireotide Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Pasireotide Sales Forecast by Country (2023-2028) & (K Units)
Table 78. Americas Pasireotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Pasireotide Sales Forecast by Region (2023-2028) & (K Units)
Table 80. APAC Pasireotide Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Pasireotide Sales Forecast by Country (2023-2028) & (K Units)
Table 82. Europe Pasireotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Pasireotide Sales Forecast by Country (2023-2028) & (K Units)
Table 84. Middle East & Africa Pasireotide Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Pasireotide Sales Forecast by Type (2023-2028) & (K Units)
Table 86. Global Pasireotide Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Pasireotide Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Pasireotide Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Pasireotide Sales Forecast by Application (2023-2028) & (K Units)
Table 90. Global Pasireotide Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Pasireotide Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Pasireotide Revenue Market Share Forecast by Application (2023-2028)
Table 93. Novartis Basic Information, Pasireotide Manufacturing Base, Sales Area and Its Competitors
Table 94. Novartis Pasireotide Product Offered
Table 95. Novartis Pasireotide Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 96. Novartis Main Business
Table 97. Novartis Latest Developments
List of Figures
Figure 1. Picture of Pasireotide
Figure 2. Pasireotide Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pasireotide Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Pasireotide Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Pasireotide Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of 0.3mg/ml
Figure 10. Product Picture of 0.6mg/ml
Figure 11. Product Picture of 0.9mg/ml
Figure 12. Global Pasireotide Sales Market Share by Type in 2021
Figure 13. Global Pasireotide Revenue Market Share by Type (2017-2022)
Figure 14. Pasireotide Consumed in Hospital
Figure 15. Global Pasireotide Market: Hospital (2017-2022) & (K Units)
Figure 16. Pasireotide Consumed in Pharmacy
Figure 17. Global Pasireotide Market: Pharmacy (2017-2022) & (K Units)
Figure 18. Global Pasireotide Sales Market Share by Application (2017-2022)
Figure 19. Global Pasireotide Revenue Market Share by Application in 2021
Figure 20. Pasireotide Revenue Market by Company in 2021 ($ Million)
Figure 21. Global Pasireotide Revenue Market Share by Company in 2021
Figure 22. Global Pasireotide Sales Market Share by Geographic Region (2017-2022)
Figure 23. Global Pasireotide Revenue Market Share by Geographic Region in 2021
Figure 24. Global Pasireotide Sales Market Share by Region (2017-2022)
Figure 25. Global Pasireotide Revenue Market Share by Country/Region in 2021
Figure 26. Americas Pasireotide Sales 2017-2022 (K Units)
Figure 27. Americas Pasireotide Revenue 2017-2022 ($ Millions)
Figure 28. APAC Pasireotide Sales 2017-2022 (K Units)
Figure 29. APAC Pasireotide Revenue 2017-2022 ($ Millions)
Figure 30. Europe Pasireotide Sales 2017-2022 (K Units)
Figure 31. Europe Pasireotide Revenue 2017-2022 ($ Millions)
Figure 32. Middle East & Africa Pasireotide Sales 2017-2022 (K Units)
Figure 33. Middle East & Africa Pasireotide Revenue 2017-2022 ($ Millions)
Figure 34. Americas Pasireotide Sales Market Share by Country in 2021
Figure 35. Americas Pasireotide Revenue Market Share by Country in 2021
Figure 36. United States Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 37. Canada Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 38. Mexico Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 39. Brazil Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 40. APAC Pasireotide Sales Market Share by Region in 2021
Figure 41. APAC Pasireotide Revenue Market Share by Regions in 2021
Figure 42. China Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 43. Japan Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 44. South Korea Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 45. Southeast Asia Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 46. India Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 47. Australia Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 48. Europe Pasireotide Sales Market Share by Country in 2021
Figure 49. Europe Pasireotide Revenue Market Share by Country in 2021
Figure 50. Germany Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 51. France Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 52. UK Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 53. Italy Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 54. Russia Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 55. Middle East & Africa Pasireotide Sales Market Share by Country in 2021
Figure 56. Middle East & Africa Pasireotide Revenue Market Share by Country in 2021
Figure 57. Egypt Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 58. South Africa Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 59. Israel Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 60. Turkey Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 61. GCC Country Pasireotide Revenue Growth 2017-2022 ($ Millions)
Figure 62. Manufacturing Cost Structure Analysis of Pasireotide in 2021
Figure 63. Manufacturing Process Analysis of Pasireotide
Figure 64. Industry Chain Structure of Pasireotide
Figure 65. Channels of Distribution
Figure 66. Distributors Profiles
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
